Document Detail


Changes in the level of serum high-temperature requirement A1 (HtrA1) during pregnancy and its relationship to preeclampsia.
MedLine Citation:
PMID:  22582805     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To investigate the expression and changes of high-temperature requirement A1 (HtrA1) during pregnancy and the use of this value in predicting preeclampsia.
METHOD: Serum samples were collected from pregnant mothers at different gestational weeks, and double-antibody sandwich enzyme-linked immunosorbent assay was employed to describe the changes in HtrA1 in serum during pregnancy.
RESULTS: (i) In Xi'an area of China, the incidence of preeclampsia was 4.95%, including 0.85% of early-onset type and 4.10% of late-onset type; (ii) the HtrA1 showed a lognormal distribution during pregnancy in the maternal serum, with the peak at 17-20 weeks of pregnancy; (iii) the HtrA1 levels in preeclampsia mothers peaked at 13-16 weeks of pregnancy, followed by acute decline until 21-24 weeks, then remained stable; (iv) the HtrA1 levels in preeclampsia mothers were higher than the control group in 13-16 weeks and lower than that in 21-24 weeks (p < 0.05); (v) the criteria using lgHtrA1 level at 1.684 during 13-16 weeks of pregnancy could predict hypertension disorders complicating pregnancy (HDCP) with sensitivity of 62.1% and specificity of 53.7%. This could be improved to 85 and 83%, respectively, when combined with body mass index as well as education background of the mother.
CONCLUSION: (i) HtrA1 showed lognormal distribution during pregnancy for all populations; (ii) HtrA1 level peaked at 17-20 weeks in normal group of pregnant mothers, and the increase of HtrA1 level in 13-16 weeks could predict the risk of preeclampsia; (iii) the risk calculation formula for preeclampsia: p (%) = eY/(1 + eY) (Y = -15.87 + 3.706 × lgHtrA1 + 0.134 × mean arterial pressure (MAP) - 1.4 × education level code); e = 2.718.
Authors:
Lu Zong; Wenli Gou; Wenyu Shao; Pu Huang; Chunfang Li
Related Documents :
20550095 - Surrogate losses: understandings of pregnancy loss and assisted reproduction among surr...
23715875 - Comparison of clinical outcomes between single and double vitrified-warmed blastocyst e...
22462005 - Flow-mediated vasodilation is not attenuated in hypertensive pregnancies despite bioche...
18468575 - Is a previous unplanned pregnancy a risk factor for a subsequent unplanned pregnancy?
17023485 - S100b protein expression in the amnion and amniotic fluid in pregnancies complicated by...
23419425 - Determinants of plasma concentrations of perfluoroalkyl substances in pregnant norwegia...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-05-14
Journal Detail:
Title:  Hypertension in pregnancy     Volume:  31     ISSN:  1525-6065     ISO Abbreviation:  Hypertens Pregnancy     Publication Date:  2012  
Date Detail:
Created Date:  2012-10-03     Completed Date:  2013-02-19     Revised Date:  2014-07-23    
Medline Journal Info:
Nlm Unique ID:  9421297     Medline TA:  Hypertens Pregnancy     Country:  England    
Other Details:
Languages:  eng     Pagination:  389-97     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / blood
Case-Control Studies
China / epidemiology
Female
Humans
Infant, Newborn
Pre-Eclampsia / blood*,  epidemiology
Pregnancy
Reference Values
Serine Endopeptidases / blood*
Chemical
Reg. No./Substance:
0/Biological Markers; EC 3.4.21.-/HtrA1 protein, human; EC 3.4.21.-/Serine Endopeptidases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Protective effects of sinomenine against doxorubicin-induced nephrosis in rats.
Next Document:  PROLIX: Rapid Mining of Protein-Ligand Interactions in Large Crystal Structure Databases.